Overview
- 29 inspections across 29 sites are on record.
- 212 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-05-07.
At a glance
Inspections
29
Sites
29
Observations
212
Career since
Jul 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Unipharma, Llc. | 7 May 2019 | Human Drugs | View 483 → |
| Innova SoftGel LLC | 14 Mar 2019 | Human Drugs | View 483 → |
| PLD Acquisitions LLC D/B/A Avema Pharma Solutions | 30 Jan 2019 | Human Drugs | View 483 → |
| Maithri Laboratories Private Limited | 7 Dec 2018 | Human Drugs | |
| Cipla Limited | 30 Nov 2018 | Human Drugs | View 483 → |
Sites inspected
Unipharma, Llc.Tamarac, United States1 insp.
Innova SoftGel LLCMiami, United States1 insp.
PLD Acquisitions LLC D/B/A Avema Pharma SolutionsDoral, United States1 insp.
Maithri Laboratories Private LimitedGaddipotharam, India1 insp.
Cipla LimitedKurkumbh Village, Dist. Pune, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Jennifer Lalama6 shared
Nicole E Knowlton5 shared
Joanne E King4 shared
Michael C Lombardi4 shared
Lissette Paiz2 shared
Marinee Flores-Marrero2 shared
Steven P Donald2 shared
Eric R Holm2 shared
Christos G Tsingelis1 shared
Jennifer L Huntington1 shared
Full investigator report
Get the verbatim findings behind Rozelle G Smith's 212 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site